IDH1/IDH2but NotTP53Mutations Predict Prognosis in Bulgarian Glioblastoma Patients
Open Access
- 1 January 2014
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2014, 1-9
Abstract
Mutations in genes encoding isocitrate dehydrogenase isoforms 1 (IDH1) and 2 (IDH2) have been associated with good prognosis for patients with brain neoplasias and have been commonly found together with mutatedTP53gene. To determine the prevalence ofIDH1,IDH2, andTP53mutations and their impact on overall survival 106 glioblastoma patients were analysed.IDH1mutations were detected in 13 andIDH2mutation in one patient. Two homozygous samples with R132H mutation inIDH1gene and a novel aberration K129R inIDH2gene were found. Sixty-four percent ofIDH1/IDH2mutated tumours harboured also a mutation inTP53gene. Genetic aberrations inTP53were present in 37 patients. Statistical analysis of the impact of the studied factors on the overall survival showed that the mutations inIDH1/IDH2, but not the ones inTP53, were associated with longer survival. Also, the impact of age on prognosis was confirmed. This is the first comprehensive study on glioblastomas in Bulgaria. Our results suggest thatIDH1/IDH2but notTP53mutations together with other prognostic factors such as age might be applied in clinical practice for prediction of outcome in patients with glioblastomas.Keywords
Funding Information
- National Science Fund, Ministry of Education, Youth and Science (DTK02-49/2009, DUNK01-2/2009, 8D-2010)
This publication has 46 references indexed in Scilit:
- Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?The Lancet Oncology, 2011
- The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 MutationsBrain Pathology, 2010
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomasActa Neuropathologica, 2010
- Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomasEuropean Journal of Endocrinology, 2010
- Molecular mechanisms of “off-on switch” of activities of human IDH1 by tumor-associated mutation R132HCell Research, 2010
- Molecular diagnostics of gliomas: the clinical perspectiveActa Neuropathologica, 2010
- Molecular diagnostics of gliomas: state of the artActa Neuropathologica, 2010
- Molecular signatures classify astrocytic gliomas by IDH1 mutation statusInternational Journal of Cancer, 2010
- Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic FactorJournal of Clinical Oncology, 2010
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010